Keyword: Merck

News

Merck KGaA Wins Chinese CRISPR Patent

24.04.2018 - China’s patent office has granted a patent application filed by German pharmaceuticals and chemicals producer Merck for use of the company’s CRISPR technology in a genomic...

News

Merck Sells Consumer Health to P&G

20.04.2018 - Germany’s Merck KGaA has signed an agreement to sell its global consumer health business to Procter & Gamble (P&G) for around €3.4 billion, or $4.2 billion, in cash. The...

Strategy & Management

Along the Acquisition Trail

17.04.2018 - For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...

Markets & Companies

ChemSpec Europe 2018: Online Partnering Program Creates Smart Networking Opportunities

28.02.2018 - ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for...

News

Merck KGaA Invests in Asian Biopharma

28.02.2018 - To support the growing demand for biopharmaceutical manufacturing capability in Asia, German pharmaceuticals and chemicals producer Merck plans to increase its spending on...

News

Interest in Consumer Drug Buys Waning?

06.02.2018 - Pharmaceutical companies’ interest in buying consumer health businesses is waning, with more players interested in shedding the activities than acquiring them, reports suggest...

News

Sanofi to Buy Hemophilia Specialist Bioverativ

24.01.2018 - Sanofi is boosting its presence in blood disorders through the acquisition of Bioverativ, the former hemophilia business of major US biotech Biogen, which was spun out in February...

News

UK Watchdog Finds Concordia Guilty of Market Abuse

30.11.2017 - In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...